Industry News
Pharmaceutical Industry News
Moderna will provide access to mRNA tech, but high-income countries will have to pay
Moderna will provide access to mRNA tech, but high-income countries will have to pay kdunleavy Tue, 03/08/2022 - 09:43
Mass General plans study of nasally delivered binge eating disorder drug
Mass General plans study of nasally delivered binge eating disorder drug ntaylor Tue, 03/08/2022 - 08:50
FDA accelerated approvals targeted for revamp in House Energy and Commerce committee chair’s new bill
FDA accelerated approvals targeted for revamp in House Energy and Commerce committee chair's new bill fkansteiner Tue, 03/08/2022 - 08:43
Fresenius Kabi recalls IV fluid after testing finds particulates
Fresenius Kabi recalls IV fluid after testing finds particulates jkeenan Tue, 03/08/2022 - 08:32
Salix works with colorectal cancer charity to catch the ‘silent killer’ before it can strike
Salix works with colorectal cancer charity to catch the 'silent killer' before it can strike sharon.coey Tue, 03/08/2022 - 07:34
And, exhale: Relief for Optinose as delivery system hits primary endpoints in chronic sinusitis phase 3
And, exhale: Relief for Optinose as delivery system hits primary endpoints in chronic sinusitis phase 3 ntaylor Tue, 03/08/2022 - 06:53
NuCana’s twist on chemo drug Gemzar fails in phase 3 again
NuCana's twist on chemo drug Gemzar fails in phase 3 again ntaylor Tue, 03/08/2022 - 06:46
Bottlenecks are slowing switch to GSK’s long-acting HIV injectable Cabenuva: clinician
Bottlenecks are slowing switch to GSK's long-acting HIV injectable Cabenuva: clinician ntaylor Tue, 03/08/2022 - 06:40
Fresenius nets NBA All-Star and transplant recipient Sean Elliot for kidney disease campaign
Fresenius nets NBA All-Star and transplant recipient Sean Elliot for kidney disease campaign nmissakian Mon, 03/07/2022 - 13:59
Fresenius nets NBA All-Star and transplant recipient Sean Elliott for kidney disease campaign
Fresenius nets NBA All-Star and transplant recipient Sean Elliott for kidney disease campaign nmissakian Mon, 03/07/2022 - 13:59
Bristol Myers Squibb’s Revlimid finally faces competition in the U.S. with Teva’s generic launch
Bristol Myers Squibb's Revlimid finally faces competition in the U.S. with Teva's generic launch kdunleavy Mon, 03/07/2022 - 11:18
Gilead drops unclear win for key Trodelvy breast cancer trial, poking holes in CEO’s oncology plan
Gilead drops unclear win for key Trodelvy breast cancer trial, poking holes in CEO’s oncology plan aliu Mon, 03/07/2022 - 10:37
Ukraine pharma CEO urges the industry to rally behind his country on three fronts
Ukraine pharma CEO urges the industry to rally behind his country on three fronts fkansteiner Mon, 03/07/2022 - 10:29
Ukraine pharma CEO urges the industry to rally behind his country on 3 fronts
Ukraine pharma CEO urges the industry to rally behind his country on 3 fronts fkansteiner Mon, 03/07/2022 - 10:29
Moderna taps Kenya as site for $500M mRNA manufacturing facility
Moderna taps Kenya as site for $500M mRNA manufacturing facility jkeenan Mon, 03/07/2022 - 10:06
Bluebird Bio has ‘doubts’ about continuing to do business through 2022, announces CFO resignation
Bluebird Bio has 'doubts' about continuing to do business through 2022, announces CFO resignation kdunleavy Mon, 03/07/2022 - 09:24
Horizon taps MasterChef winner Christine Ha to add culinary marketing flair to vision disease awareness
Horizon taps MasterChef winner Christine Ha to add culinary marketing flair to vision disease awareness badams Mon, 03/07/2022 - 09:02
Eli Lilly, Boehringer Ingelheim’s Jardiance turns up heat on AstraZeneca’s Farxiga with broad EU heart failure approval
Eli Lilly, Boehringer Ingelheim's Jardiance turns up heat on AstraZeneca's Farxiga with broad EU heart failure approval fkansteiner Mon, 03/07/2022 - 08:50
Roche’s Vabysmo to offer ‘fierce competition’ to Regeneron’s Eylea, but a long market battle awaits: Spherix
Roche’s Vabysmo to offer ‘fierce competition’ to Regeneron’s Eylea, but a long market battle awaits: Spherix badams Mon, 03/07/2022 - 08:14
In ultrafast FDA nod, Bristol Myers’ Opdivo catapults I-O therapy to pre-surgery lung cancer with first glimpse of key data
In ultrafast FDA nod, Bristol Myers' Opdivo catapults I-O therapy to pre-surgery lung cancer with first glimpse of key data aliu Mon, 03/07/2022 - 04:19